BC Innovations | Feb 28, 2019
Distillery Therapeutics

Infectious disease

INDICATION: Encephalitis Mouse studies suggest inhibiting CMA1 could help treat Japanese encephalitis (JE). In mice non-lethally infected with JE virus, serum levels of a mouse homolog of CMA1 were higher after infection with JE virus...
BC Week In Review | Feb 11, 2013
Clinical News

ASB17061: Phase II started

In its fiscal 3Q12 earnings ending Dec. 31, 2012, Daiichi said it began a double-blind, placebo-controlled, U.S. Phase II trial to evaluate 3 dose levels of oral ASB17061 once daily for 28 days in about...
Items per page:
1 - 2 of 2